Table 4-.

Clinical characteristics of HIV positive patients by anti-retroviral (ART) use at breast cancer diagnosis

	Not on ART (n=63) **	On ART (n=160) **	P-value*
Stage at BC diagnosis
Early Stage	18 (28.6%)	65 (40.9%)	0.09
Late Stage	45 (71.4%)	94 (59.1%)
Metastatic disease
No metastasis	47 (74.6%)	137 (85.6%)	0.05
Metastasis	16 (25.4%)	23 (14.4%)
IHC4 subtypes at diagnosis
Luminal A	5 (8.3%)	18 (12.0%)	0.74‡
Luminal B	42 (70.0%)	94 (62.7%)
Her2-positive	4 (6.7%)	9 (6.0%)
Triple Negative	9 (15.0%)	29 (19.3%)
Luminal B (ER+/PR+; Her2-; Ki67≥14%)	28 (66.7%)	57 (60.6%)	0.50
Luminal B (ER+/PR+; Her2+)	14 (33.3%)	37 (39.4%)

^*Chi square test,

^‡Fisher’s exact test and

^#Mann Whitney test comparing use of ART.

^**ART use missing for 3 HIV positive patients (1.3%).